Variant report
Variant | nsv524353 |
---|---|
Chromosome Location | chr3:98436188-98439637 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:98438833..98441641-chr3:98449159..98451733,2 | MCF-7 | breast: |
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-DCBLD2-1 | chr3:98437263-98437365 | ENSG00000239445.1 |
2 | lnc-DCBLD2-1 | chr3:98437263-98437365 | NR_046683 |
3 | lnc-DCBLD2-1 | chr3:98437268-98437365 | ENSG00000239445.1 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000239445 | chromatin interactions |
ENSG00000064225 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs12635955 | chr3:98436188-98436189 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs541825306 | chr3:98436211-98436212 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs546303694 | chr3:98436273-98436274 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs562694824 | chr3:98436280-98436281 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs35062769 | chr3:98436354-98436355 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs531741652 | chr3:98436432-98436433 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs182461125 | chr3:98436451-98436452 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs186984617 | chr3:98436454-98436455 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs527606764 | chr3:98436474-98436475 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs189760663 | chr3:98436511-98436512 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs563451050 | chr3:98436558-98436559 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs371043898 | chr3:98436562-98436563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs114859181 | chr3:98436563-98436564 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs182183492 | chr3:98436565-98436566 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs543626041 | chr3:98436621-98436622 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs116823988 | chr3:98436645-98436646 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs9858592 | chr3:98436753-98436754 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
18 | rs11716001 | chr3:98436756-98436757 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs555430855 | chr3:98436840-98436841 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs575170401 | chr3:98436843-98436844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs539656158 | chr3:98436844-98436845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs199994560 | chr3:98436846-98436847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs278368 | chr3:98436847-98436848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs142877358 | chr3:98436866-98436867 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs75245437 | chr3:98436867-98436868 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs12496694 | chr3:98436880-98436881 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
27 | rs372526296 | chr3:98436953-98436954 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs111884611 | chr3:98436960-98436961 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs577374566 | chr3:98437032-98437033 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs545939332 | chr3:98437041-98437042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs371352422 | chr3:98437056-98437057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs531755921 | chr3:98437070-98437071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs541797766 | chr3:98437098-98437099 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs146296964 | chr3:98437102-98437103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs9858954 | chr3:98437140-98437141 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
36 | rs547310561 | chr3:98437233-98437234 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs548268310 | chr3:98437241-98437242 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs570506232 | chr3:98437244-98437245 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs139426511 | chr3:98437247-98437248 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs187189959 | chr3:98437258-98437259 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs569712313 | chr3:98437296-98437297 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs535232512 | chr3:98437322-98437323 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs548966016 | chr3:98437336-98437337 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs564213331 | chr3:98437492-98437493 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs142635747 | chr3:98437494-98437495 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs534449877 | chr3:98437502-98437503 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs190026093 | chr3:98437503-98437504 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs550858330 | chr3:98437511-98437512 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs540019483 | chr3:98437549-98437550 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs72930960 | chr3:98437559-98437560 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
microdeletion syndrome | 22180640 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Epilepsy | 21858020 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:98425600-98438600 | Weak transcription | Aorta | Aorta |
2 | chr3:98431000-98449200 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
3 | chr3:98432800-98437400 | Weak transcription | Placenta | Placenta |
4 | chr3:98433400-98446000 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr3:98436200-98436400 | Enhancers | Stomach Mucosa | stomach |
6 | chr3:98437200-98438000 | Enhancers | GM12878-XiMat | blood |
7 | chr3:98437400-98437800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
8 | chr3:98437400-98438400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
9 | chr3:98437400-98438400 | Enhancers | Placenta | Placenta |
10 | chr3:98438200-98438600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
11 | chr3:98438400-98438600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
12 | chr3:98438400-98441800 | Weak transcription | Placenta | Placenta |
13 | chr3:98438600-98441400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
14 | chr3:98438800-98441000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
15 | chr3:98439400-98439600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
16 | chr3:98439600-98440800 | Weak transcription | HUES6 Cell Line | embryonic stem cell |